Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer
Clinical trial NCT02132845 · COMPLETED
Trial details
- NCT number
- NCT02132845
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-17
- Primary completion
- 2018-05-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.